CHEK1 and sarcoma: By analyzing data from TCGA sarcoma cohort, we further confirmeda strong positive correlation between RRM2 and cyclin B1, cyclin E1,and CHEK1 expression, as well as a negative correlation with TP53expression (Figure S5).